Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is -7.09% vs 36.22% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is -84.73% vs 147.75% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is -24.06% vs 26.76% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 64.75% vs 22.82% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025
Compare Quarterly Results Of Nath Bio-Genes With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is -87.59% vs 536.56% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -7.09% vs 36.22% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is -98.70% vs 3,22,700.00% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -84.73% vs 147.75% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is -86.80% vs 684.60% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -24.06% vs 26.76% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 41.55% vs -7.19% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 64.75% vs 22.82% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025